Glasgow Uni makes breakthrough in treatment for schizophrenia

Research led by the University of Glasgow has made a breakthrough in developing a possible future treatment of schizophrenia and related psychiatric conditions.

Studies currently show that people with a hereditary form of schizophrenia, are deficient in the brain protein DISC1 - vital to key brain functions.

This ground-breaking study, published today in Molecular Psychiatry, identifies a peptide that stabilises DISC1 levels.

In turn, this will pave the way for a possible treatment for schizophrenia and related conditions.

11 Likes

How man.??? Edu can u expain it in 4 lines…?? How iz this gonna be a breakthrough …

2 Likes

I can explain it in one (I’m on my phone though so the lines are shorter).

One promising step closer to the cure!

2 Likes

It says that people with hereditary sz are deficient in a protein called DISC1. They are inventing a peptide which will raise the levels of DISC1, and maybe that will help.

3 Likes

Hey edu what should i call u 50 cent or coolio …???

1 Like

You can find me in the club with a bottle full of buzz.

3 Likes

Hahahaha ggggg unittttt…???

Hey edu i swear .u were looking good on pics…man…

1 Like

I chose the best pic to show you. I look like :poop: From many angles.

STOP DERAILING MY THREAD THIS IS AN IMPORTANT DISCOVERY!

5 Likes

I never got to see pics of @eduvigis
Now I am curious af…

2 Likes

Andrey is this news any benifit .???

Is this a real breakthrough…???

We don’t know yet. It hasn’t been tested on ill patients. We must wait until they start clinical trials…

1 Like

so the cure is near?

They havent tested yet in human…why they call it a breakthrough …!!!

Isnt this type of news are misleading…!!!

To make sensation.
The world nowadays is so busy, they need to use strong words in the title, otherwise nobody would open the article.

1 Like

Nonetheless, this is still good news. I am so tired from this illness!

Damn I can’t access the link, can you post key points? Maybe the news will be covered elsewhere too.

:This is the whole short article twinklestars:

"Research led by the University of Glasgow has made a breakthrough in developing a possible future treatment of schizophrenia and related psychiatric conditions.

Studies currently show that people with a hereditary form of schizophrenia, are deficient in the brain protein DISC1 - vital to key brain functions.

This ground-breaking study, published today in Molecular Psychiatry, identifies a peptide that stabilises DISC1 levels.

In turn, this will pave the way for a possible treatment for schizophrenia and related conditions.

For the first time, scientists identified the protein, FBXW7, which tags the DISC1 protein for destruction.

They discovered that by disrupting the interaction between these two proteins with and inhibitory peptide, DISC1 deficiencies could be counteracted.

Lead author George Baillie, Professor of Molecular Pharmacology at the Institute of Cardiovascular and Medical Sciences, said: “My colleagues and I decided to look specifically at the DISC1 protein."

"Our idea was simple: what would happen if we could simply raise the concentration of DISC1 in patients’ brains?

“ If we can stop the natural destruction of DISC1, people with low levels would see it naturally increase.

"Using our peptide, we can now restore DISC1 concentrations in psychiatric patient derived brain cells back to the levels of control subjects.”
Schizophrenia affects around 1 in 100 people over the course of their life.

It is present in twice as many people as Alzheimer’s Disease and five times as many people as Multiple Sclerosis, with an estimated cost to the economy of £6.7 billion each year.

Professor Baillie added: “Many patients respond inadequately or adversely to current psychiatric medications, so the development of new drugs to treat mental illness is needed.
"Unfortunately no substantial innovations in drug treatments for these debilitating disorders have emerged in the last 60 years.

"We are hopeful that our peptide can be a stepping stone toward a novel therapeutic in the future to counteract this unmet need.” "

2 Likes